Viewing Study NCT06698003

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:40 PM
Ignite Modification Date: 2026-01-25 @ 8:00 AM
Study NCT ID: NCT06698003
Status: RECRUITING
Last Update Posted: 2025-03-04
First Post: 2024-11-18
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None T-Cell Leukemia/Lymphoma, Adult View
None T-cell Leukemia/Lymphoma View
None T-cell Leukemia View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None T-Cell Leukemia/Lymphoma, Adult View
None T-cell Leukemia/Lymphoma View
None T-cell leukemia View
None Lymphoma View
None Mogamulizumab View
None HTLV-1 View
None Memorial Sloan Kettering Cancer Center View
None 21-486 View